Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas

European Journal of Cancer

Volumn 34, Issue 10, 1998, Pages 1570-1574

  Van Den Bent, M J ^b   Schellens, J H M ^a   Vecht, Ch J ^b   Sillevis Smit, P A E ^b   Loosveld, O J L ^a   Ma, J ^a   Tijssen, C C ^b   Jansen, R L H ^c   Kros, J M ^d   Verweij, J ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b St Elisabeth Gasthuis ^*

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Cisplatin; Glioma; Ifosfamide; Oligoastrocytoma; Recurrent

Indexed keywords

CISPLATIN; IFOSFAMIDE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DOSE RESPONSE; FEMALE; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SEPSIS; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CISPLATIN; FEMALE; GLIOMA; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 17644446972     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00138-5     Document Type: Article

References (29)

1. 1. Fine HA, Dear KBG, Loeffler JS, Black PMcL, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993, 71, 2585-2597.
2. 2. Ammirati M, Galicich JH, Arbit E, Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurg 1987, 21, 607-614.
3. 3. Vick NA, Ciric IS, Eller TW, Cozzens JW, Walsh A. Reoperation for malignant astrocytoma. Neurology 1989, 39, 430-432.
4. 4. Goldin A. Ifosfamide in experimental tumor systems. Semin Oncol 1982, 9, 14-23.
5. 5. Graziano S, Herndon JE, Richards F, et al. A phase I trial of ifosfamide, mesna and cisplatin in advanced non-small cell lung cancer. Cancer 1993, 72, 62-68.
6. 6. Green JA, Slater ALJ. A study of cisplatinum and ifosfamide in alkylating agent-resistant ovarian cancer. Gynecol Oncol 1989, 32, 233-235.
7. 7. Becher R, Seeber S, Schmidt CG. Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma. J Cancer Res Clin Oncol 1980, 97, 301-306.
8. 8. Verweij J, Planting AST, Gaast A van de, Stoter G. Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanoma. Ann Oncol 1990, 1, 77-78.
9. 9. Ma J, Verweij J, Kolker HJ, Ingen HE van, Stoter G, Schellens JHM. Pharmacokinetic-dynamic relationship of cisplatin in vitro simulation of an iv bolus, 3h and 20h infusion. Br J Cancer 1994, 69, 858-862.
10. 10. Spence AM, Berger MS, Livingston RB, Ali-Osman F, Griffin B. Phase II evaluation of high-dose intravenous cisplatin for the treatment of adult malignant gliomas recurrent after chloroethylnitrosurea failure. J Neurooncol 1992, 12, 187-191.
11. 11. Stewart DJ, O'Bryan RM, Al-Sarraf M, Costanzi JJ, Oishi N. Phase II study of cisplatin in recurrent astrocytomas in adults: a southwest oncology group study. J Neurooncol 1983, 1, 145-147.
12. 12. Grunberg SM, Bertram JH, MeDermed JE, Apuzzo MLJ. Treatment of astrocytoma with a 5-day cisplatin infusion. Cancer Drug Delivery 1987, 4, 47-53.
13. 13. Warnick RE, Prados MD, Mack EE, et al. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neurooncol 1994, 19, 69-74.
14. 14. Poisson M, Pereon Y, Chiras J, Delattre JY. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA). J Neurooncol 1991, 10, 139-144.
15. 15. Yung WKA, Mechtler L, Gleason MJ. Intravenous carboplatin for recurrent malignant glioma: a phase II study. J Clin Oncol 1991, 9, 860-864.
16. 16. Elliott TE, Buckner JC, Cascino TL, Levitt R, O'Fallon JR, Scheithauer BW. Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma. J Neurooncol 1991, 10, 27-30.
17. 17. Pratt CB, Douglass EC, Kovnar EH, et al. A phase I study of ifosfamide given on alternative days to treat children with brain tumors. Cancer 1993, 71, 3666-3669.
18. 18. Heideman RL, Douglass EC, Langston JA, et al. A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study. J Neurooncol 1995, 25, 77-84.
19. 19. Jeremic B, Grujicic D, Jevremovic S, et al. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study. J Clin Oncol 1992, 10, 1074-1077.
20. 20. Buckner LC, Brown LD, Cascino TL, et al. Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma. J Neurooncol 1990, 9, 249-254.
21. 21. Ameri A, Poisson M, Chauveinc L, Chen QM, Delattre JY. Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study. J Neurooncol 1997, 32, 155-160.
22. 22. Sanson M, Ameri A, Monjour A, et al. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. Eur J Cancer 1996, 32A, 2229-2235.
23. 23. Rajan B, Ross G, Lim CC, et al. Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosurea chemotherapy. Eur J Cancer 1994, 30A, 1809-1815.
24. 24. Walker RW, Cairncross JG, Posner JB. Cerebal herniation in patients receiving cisplatin. J Neurooncol 1988, 6, 61-65.
25. 25. Ichimura K, Ohno K, Aoyagi M, Tamaki M, Suzuki R, Hirakawa K. Capillary permeability in experimental rat glioma and effects of intracarotid CDDP administration on tumor drug delivery. J Neurooncol 1993, 1993, 211-215.
26. 26. Stewart DJ, Leavens M, Maor M, et al. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 1982, 42, 2474-2479.
27. 27. Stewart DJ, Mikhael NZ, Nair RC, et al. Platinum concentrations in human autopsy tumor samples. Am J Clin Oncol (CCT) 1988, 11, 152-158.
28. 28. Stewart DJ, Molepo MJ, Eapen L, et al. Cisplatin and radiation in the treatment of tumors of the central nervous system: pharmacological considerations and results of early studies. Int J Radiat Oncol Biol Phys 1993, 28, 531-542.
29. 29. Nakagawa H, Fujita T, Izumoto S, et al. Cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer. J Neurooncol 1993, 16, 61-67.